Paclitaxel with Cisplatin as Salvage Treatment for Patients with Previously Treated Advanced Transitional Cell Carcinoma of the Urothelial Tract-Reference-Cited by-同舟云学术

Paclitaxel with Cisplatin as Salvage Treatment for Patients with Previously Treated Advanced Transitional Cell Carcinoma of the Urothelial Tract

Published:2007-01 Issue:1 Volume:9 Page:18-22
ISSN:1476-5586
Container-title:Neoplasia
language:en
Short-container-title:Neoplasia

Author:

Uhm Ji Eun,Lim Ho Yeong,Kim Won Seog,Choi Han Yong,Lee Hyun Moo,Park Byeong-Bae,Park Keunchil,Kang Won Ki

Publisher

Elsevier BV

Subject

Cancer Research

Reference25 articles.

1. Paclitaxel and carboplatin in bladder cancer: recent developments;Vaughn;Eur J Cancer,2000

2. Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy;Bajorin;J Clin Oncol,1999

3. Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I/II trial with paclitaxel, cisplatin, and gemcitabine;Bellmunt;Cancer,2002

4. Chemotherapy for urothelial tract malignancies: breaking the deadlock;Scher;Semin Surg Oncol,1992

5. Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium;Sternberg;Efficacy and patterns of response and relapse. Cancer,1989

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Four-weekly Low-dose Gemcitabine and Paclitaxel in Patients With Platinum-resistant Urothelial Cancer and Performance Status 2/3;In Vivo;2019

2. Second-line Chemotherapy in Older Patients With Metastatic Urothelial Carcinoma: Pooled Analysis of 10 Second-line Studies;Clinical Genitourinary Cancer;2017-08

3. Second-Line Chemotherapy for Metastatic Urothelial Carcinoma: Importance of Lymph Node-Only Metastasis as a Prognostic Factor and Construction of a Prognostic Model;Clinical Genitourinary Cancer;2016-06

4. Comparison of single agent versus combined chemotherapy in previously treated patients with advanced urothelial carcinoma: a meta-analysis;OncoTargets and Therapy;2016-03

5. Second-line single-agent versus doublet chemotherapy as salvage therapy for metastatic urothelial cancer: a systematic review and meta-analysis;Annals of Oncology;2016-01